Comparison of Two Types of Biopsy Needles for EUS-FNB in Solid Pancreatobiliary Mass Lesions
Pancreatic Neoplasms
About this trial
This is an interventional diagnostic trial for Pancreatic Neoplasms focused on measuring Fine needle biopsy, Endoscopic ultrasonography, Diagnosis
Eligibility Criteria
Inclusion Criteria:
- Inpatients and outpatients 18 years of age or older with solid mass lesions in the pancreas or extrahepatic biliary system
Exclusion Criteria:
- Uncorrectable coagulopathy (INR > 1.5)
- Uncorrectable thrombocytopenia (platelet < 50,000)
- Decline to participate in the study and sign the informed consent form
- Cystic lesions.
Sites / Locations
- Digestive Diseases Research Institute, Shariati Hospital, North Kargar Ave.,
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Franseen needle with three symmetric cutting edges
Multi-blade needle with three-prong tip with one tip longer than the other two
These patients will undergo endoscopic ultrasound-guided fine needle biopsy using the Franseen needle (Acquire FNB needle; Boston Scientific): eight back and forth movements within the lesion will be performed with simultaneous minimal negative pressure provided by withdrawing the needle stylet slowly. Four passes of FNB will be made from each mass lesion and the specimens from each pass will be placed in different containers for cell block preparation and histologic evaluation.
These patients will undergo endoscopic ultrasound-guided fine needle biopsy using a multi-blade three-prong tip needle (Trident; Microtech): eight back and forth movements within the lesion will be performed with simultaneous minimal negative pressure provided by withdrawing the needle stylet slowly. Four passes of FNB will be made from each mass lesion and the specimens from each pass will be placed in different containers for cell block preparation and histologic evaluation.